Cargando…

Survival of chronic hemodialysis patients over 80 years of age

BACKGROUND/AIM: The number of elderly patients with chronic kidney disease (CKD) stage 5 management with hemodialysis (HD) is steadily increasing. Therefore we analyzed the number of new CKD patients ≥80 years managed with HD and their survival through the study period. We aimed also, to identify wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sladoje-Martinovic, Branka, Mikolasevic, Ivana, Bubic, Ivan, Racki, Sanjin, Orlic, Lidija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998852/
https://www.ncbi.nlm.nih.gov/pubmed/24790421
http://dx.doi.org/10.2147/CIA.S58976
_version_ 1782313421907165184
author Sladoje-Martinovic, Branka
Mikolasevic, Ivana
Bubic, Ivan
Racki, Sanjin
Orlic, Lidija
author_facet Sladoje-Martinovic, Branka
Mikolasevic, Ivana
Bubic, Ivan
Racki, Sanjin
Orlic, Lidija
author_sort Sladoje-Martinovic, Branka
collection PubMed
description BACKGROUND/AIM: The number of elderly patients with chronic kidney disease (CKD) stage 5 management with hemodialysis (HD) is steadily increasing. Therefore we analyzed the number of new CKD patients ≥80 years managed with HD and their survival through the study period. We aimed also, to identify which of several key variables might be independently associated with survival in this very elderly population of patients. PATIENTS AND METHODS: This was a single-center, retrospective cohort study that took place during the period from January 1987 to September 2012. The study consisted of 78 (50 male and 28 women) very elderly patients (≥80 years of age); the mean age at which HD was initiated was 83.2±2.5 years. Survival and factors associated with mortality were studied. Survival was defined as the time from start of HD treatment to death (or end of study, if still alive). RESULTS: In the period from 1987 to 2002, patients ≥80 years of age were only sporadically treated with HD, but since 2003, the number of new patients has been steadily increasing. The mean survival for our group of patients was 25.1±22.4 months (range 1–115 months). Furthermore, 30.8% patients survived <12 months, 29.5% patients survived 12–24 months, 30.8% patients survived 24–60 months, and 9% patients survived >60 months on HD treatment. Older patients were less likely to have diabetes, and primary renal disease did not influence survival. Patients with high C-reactive protein levels and poor nutritional status, as well as those who did not have pre-HD nephrology care and those that had a catheter as vascular access for HD had poor survival. In about half of our patients, the cause of death was cardiovascular disease. CONCLUSION: Among patients who were ≥80 years of age at the start of HD treatment, those who received pre-HD nephrology care that followed a planned management pathway, those who had a good nutritional status, and those with an arteriovenous fistula as vascular access for HD at the time of HD initiation had a better survival.
format Online
Article
Text
id pubmed-3998852
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39988522014-04-30 Survival of chronic hemodialysis patients over 80 years of age Sladoje-Martinovic, Branka Mikolasevic, Ivana Bubic, Ivan Racki, Sanjin Orlic, Lidija Clin Interv Aging Original Research BACKGROUND/AIM: The number of elderly patients with chronic kidney disease (CKD) stage 5 management with hemodialysis (HD) is steadily increasing. Therefore we analyzed the number of new CKD patients ≥80 years managed with HD and their survival through the study period. We aimed also, to identify which of several key variables might be independently associated with survival in this very elderly population of patients. PATIENTS AND METHODS: This was a single-center, retrospective cohort study that took place during the period from January 1987 to September 2012. The study consisted of 78 (50 male and 28 women) very elderly patients (≥80 years of age); the mean age at which HD was initiated was 83.2±2.5 years. Survival and factors associated with mortality were studied. Survival was defined as the time from start of HD treatment to death (or end of study, if still alive). RESULTS: In the period from 1987 to 2002, patients ≥80 years of age were only sporadically treated with HD, but since 2003, the number of new patients has been steadily increasing. The mean survival for our group of patients was 25.1±22.4 months (range 1–115 months). Furthermore, 30.8% patients survived <12 months, 29.5% patients survived 12–24 months, 30.8% patients survived 24–60 months, and 9% patients survived >60 months on HD treatment. Older patients were less likely to have diabetes, and primary renal disease did not influence survival. Patients with high C-reactive protein levels and poor nutritional status, as well as those who did not have pre-HD nephrology care and those that had a catheter as vascular access for HD had poor survival. In about half of our patients, the cause of death was cardiovascular disease. CONCLUSION: Among patients who were ≥80 years of age at the start of HD treatment, those who received pre-HD nephrology care that followed a planned management pathway, those who had a good nutritional status, and those with an arteriovenous fistula as vascular access for HD at the time of HD initiation had a better survival. Dove Medical Press 2014-04-16 /pmc/articles/PMC3998852/ /pubmed/24790421 http://dx.doi.org/10.2147/CIA.S58976 Text en © 2014 Sladoje-Martinovic et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sladoje-Martinovic, Branka
Mikolasevic, Ivana
Bubic, Ivan
Racki, Sanjin
Orlic, Lidija
Survival of chronic hemodialysis patients over 80 years of age
title Survival of chronic hemodialysis patients over 80 years of age
title_full Survival of chronic hemodialysis patients over 80 years of age
title_fullStr Survival of chronic hemodialysis patients over 80 years of age
title_full_unstemmed Survival of chronic hemodialysis patients over 80 years of age
title_short Survival of chronic hemodialysis patients over 80 years of age
title_sort survival of chronic hemodialysis patients over 80 years of age
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998852/
https://www.ncbi.nlm.nih.gov/pubmed/24790421
http://dx.doi.org/10.2147/CIA.S58976
work_keys_str_mv AT sladojemartinovicbranka survivalofchronichemodialysispatientsover80yearsofage
AT mikolasevicivana survivalofchronichemodialysispatientsover80yearsofage
AT bubicivan survivalofchronichemodialysispatientsover80yearsofage
AT rackisanjin survivalofchronichemodialysispatientsover80yearsofage
AT orliclidija survivalofchronichemodialysispatientsover80yearsofage